BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Daiichi Suntory Pharma Co., Ltd. 

No.31 Kojimachi MT Building
5-7-2 Kojimachi
Chiyoda-ku  Tokyo  102-8530  Japan
Phone: Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Sepracor, Inc. (SEPR) Announces Resignation of Adrian Adams as President and CEO and Plans for Merger with Daiichi Suntory Pharma Co., Ltd. 2/19/2010 6:23:32 AM
Daiichi Suntory Pharma Co., Ltd. to Move Clot Prevention Drug to Phase 3 10/31/2008 6:30:06 AM
BioMarin Pharmaceutical Inc. (BMRN) Initiates Phase 3 Clinical Trial Of Phenoptin For PKU10/19/2005 5:13:14 PM
Yamanouchi Pharmaceutical Co., Ltd. Terminates Marketing Agreement With Daiichi Suntory Pharma Co., Ltd.10/19/2005 5:12:46 PM
Torre Lazur McCann Creates Consumer Group10/19/2005 5:12:22 PM
Daiichi Suntory Pharma Co., Ltd., BioMarin Pharmaceutical Inc. (BMRN) To Enter Into Licensing Agreement For Phenoptin For The Treatment Of PKU10/19/2005 5:12:19 PM
BioMarin Pharmaceutical Inc. (BMRN) Forms Strategic Partnership With Daiichi Suntory Pharma Co., Ltd. For Phenoptin To Treat Phenylketonuria10/19/2005 5:12:17 PM
Daiichi Pharmaceutical (JPN) Acquires Daiichi Suntory Pharma Co., Ltd. As Wholly Owned Subsidiary For 20 Billion Yen10/19/2005 5:12:11 PM
BioMarin Pharmaceutical Inc. (BMRN) Acquires Rights To Daiichi Suntory Pharma Co., Ltd.'s 6R-BH4 For Treating Vascular Dysfunction In Diabetes And Cardiovascular Disease10/19/2005 5:10:30 PM
Daiichi Suntory Pharma Co., Ltd. To Change Its Name To Daiichi Asubio Pharma10/19/2005 5:09:46 PM
12